PPA-Containing NDA Drugs, Weight-Control Aids Subject Of FDA Formal Notice
This article was originally published in The Tan Sheet
Executive Summary
An FDA notice giving new drug application and ANDA holders an opportunity to object to FDA's plans to withdraw approval for PPA-containing decongestants also applies to manufacturers of extended-release weight-control products containing the ingredient, according to the agency.